Advertisement

Topics

Trifecta Aortic Bioprosthesis: Midterm Results in 1,953 Patients from a Single Center.

07:00 EST 1st December 2018 | BioPortfolio

Summary of "Trifecta Aortic Bioprosthesis: Midterm Results in 1,953 Patients from a Single Center."

The St. Jude Medical Trifecta bioprosthesis is a bovine pericardial valve mounted on a titanium stent. The objective of this study was to report a single center experience with the Trifecta aortic valve.

Affiliation

Journal Details

This article was published in the following journal.

Name: The Annals of thoracic surgery
ISSN: 1552-6259
Pages:

Links

DeepDyve research library

PubMed Articles [39956 Associated PubMed Articles listed on BioPortfolio]

Trifecta Aortic Bioprosthesis: Midterm Results in 1,953 Patients from a Single Center (Commentary).

Late onset valve dislocation of the Edwards Intuity rapid-deployment bioprosthesis.

Over the last decade, aortic valve replacement with rapid-deployment biological bioprosthesis has become a common alternative technique to mechanical or biological stented valves for high-risk patient...

Excessive pannus overgrowth on the aortic side of Trifecta valve determining severe regurgitation.

Structural valve deterioration represents the most important concern regarding the implantation of a biological heart valve in young patients. Several strategies have been proposed to improve prosthes...

Transprosthetic cuff leakage of a bovine pericardial aortic bioprosthesis.

The Carpentier-Edwards PERIMOUNT Magna aortic heart valve is the most frequently implanted bioprosthesis. However, the existence of transvalvular cuff leakage necessitating a second cross clamp has be...

Thromboembolic acute myocardial infarction after aortic valve replacement using the Freestyle stentless aortic bioprosthesis with subcoronary valve replacement.

A 70-year-old woman with substernal chest pain lasting 2.5 h presented to the emergency department of our hospital. She had a history of aortic valve replacement with the Freestyle stentless aortic bi...

Clinical Trials [7041 Associated Clinical Trials listed on BioPortfolio]

Aortic Valve Replacement With Trifecta(TM)

The purpose of this study is to confirm the clinical safety and effectiveness of the Trifecta valve.

Aortic Valve Replacement With Trifecta(TM)

To confirm the clinical safety and effectiveness of the Trifecta valve.

ATS 3f Enable(tm) Aortic Bioprosthesis, Model 6000

This is a prospective, non-randomized, multi-center study designed to evaluate safety and effectiveness of the ATS 3f Enable Aortic Bioprosthesis in a patient population undergoing isolate...

ATS 3f(r) Aortic Bioprosthesis Model 1000 Post Approval Study

The purpose of this clinical study is to determine if there is an increased incidence and rate of aortic regurgitation in younger (

ACURATE TF™ Transfemoral Aortic Bioprosthesis for Implantation in Patients With Severe Aortic Stenosis (2011-03)

First-In-Man Study on the ACURATE TF™ Transfemoral Aortic Bioprosthesis Implantation in Patients with Severe Aortic Stenosis to collect human feasibility data pertaining to the safety an...

Medical and Biotech [MESH] Definitions

Surgical treatment for severe AORTIC VALVE STENOSIS. Transcatheter aortic valve replacement (TAVR) is used as an alternative option in patients who are deemed at high risk or inoperable for traditional open-heart surgery.

Small clusters of chemoreceptive and supporting cells located near the ARCH OF THE AORTA; the PULMONARY ARTERIES; and the coronary arteries. The aortic bodies sense PH; CARBON DIOXIDE; and oxygen concentrations in the BLOOD and participate in the control of RESPIRATION. The aortic bodies should not be confused with the PARA-AORTIC BODIES in the abdomen (which are sometimes also called aortic bodies).

Small masses of chromaffin cells found near the SYMPATHETIC GANGLIA along the ABDOMINAL AORTA, beginning cranial to the superior mesenteric artery (MESENTERIC ARTERY, SUPERIOR) or renal arteries and extending to the level of the aortic bifurcation or just beyond. They are also called the organs of Zuckerkandl and sometimes called aortic bodies (not to be confused with AORTIC BODIES in the THORAX). The para-aortic bodies are the dominant source of CATECHOLAMINES in the FETUS and normally regress after BIRTH.

Pathological condition characterized by the backflow of blood from the ASCENDING AORTA back into the LEFT VENTRICLE, leading to regurgitation. It is caused by diseases of the AORTIC VALVE or its surrounding tissue (aortic root).

The downward displacement of the cuspal or pointed end of the trileaflet AORTIC VALVE causing misalignment of the cusps. Severe valve distortion can cause leakage and allow the backflow of blood from the ASCENDING AORTA back into the LEFT VENTRICLE, leading to aortic regurgitation.

Advertisement
Quick Search
Advertisement
Advertisement

 


DeepDyve research library

Relevant Topic

Acute Coronary Syndromes ACS
Acute Coronary Syndromes (ACS) is an umbrella term for situations where the blood supplied to the heart muscle is suddenly blocked. Treatment for acute coronary syndrome includes medicines and a procedure known as angioplasty, during which doctors inflat...


Searches Linking to this Article